Global foundation-governed pharmaceutical group focused on cardiology, targeted oncology, neurosciences and immuno-inflammatory diseases. Develops innovative, precision-targeted medicines for patients with hard-to-treat cancers and profile-driven neurological and immune conditions, integrating patient input across the drug lifecycle.